FDA Plans Meetings For Vaccine Authorization
SOURCE SAYS FDA MEETING SCHEDULED FOR DECEMBER IS TO DISCUSS MODERNA'S COVID-19 VACCINE
(CNN) – It looks like the Food and Drug Administration is getting closer to approving two COVID-19 vaccines.
The agency has asked members of its Vaccine Advisory Committee to reserve December 17th and 18th for meetings.
A source says those meetings are to discuss a vaccine developed by Moderna.
Another meeting, already on the books for December tenth will focus on Pfizer’s application for emergency use for its vaccine.
Moderna and Pfizer both claim their vaccine candidates are 95% effective.
Moderna is still waiting for some data related to study participants who contracted COVID-19, but the company says it could apply for emergency use authorization as early as next week.
The FDA consults with its vaccines and related biological products advisory committee before allowing any vaccine to go to market.